Feasibility and Safety of CareMin650 in Patients at Risk of or Suffering From Oral Mucositis and/or Radiation Dermatitis (SafePBM)
Feasibility and Safety of CareMin650 in Cancer Patients at High Risk of or Suffering From Oral Mucositis and/or Radiation Dermatitis Due to the Administration of Radiotherapy: A Prospective Non-comparative Study
Sponsor: NeoMedLight
Listed as NCT03988556, this NA trial focuses on Oral Mucositis Due to Radiation and Radiation Dermatitis and remains completed. Sponsored by NeoMedLight, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2021 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jul 2019 — Oct 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- NeoMedLight
- Qualissima
For direct contact, visit the study record on ClinicalTrials.gov .